Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorDeutsches Herzzentrum Muenchen
About this trial
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
Eligibility criteria
Qualifiers
Transcatheter Tricuspid Valve Replacement
Disqualifiers
no defined exclusion criteria
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov